The growth of the antibacterial susceptibility testing systems market is mainly driven by the increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods, growing number of hospitals across major markets. Moreover, rising R&D investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.
According to research report Antimicrobial Susceptibility Testing Market is projected to reach $4.2 billion by 2025, at a CAGR of 5.5% during the forecast period.
Based on type, the antibacterial susceptibility testing systems market has been segmented into the antibacterial susceptibility testing, antiparasitic susceptibility testing, antifungal susceptibility testing and susceptibility testing types. The antibacterial susceptibility testing segment dominated the market in 2019. The major share of the segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries.
Based on the product, the antimicrobial susceptibility testing market is segmented into manual antimicrobial susceptibility testing products, automated laboratory instruments, culture and growth media, and consumables. The manual susceptibility testing products segment is further divided into susceptibility testing disks, MIC strips, and susceptibility testing plates. Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019. The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries. Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).
bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker (US), Bio-Rad Laboratories, Inc. (US), Creative Diagnostics (US), Synbiosis (UK), Bioanalyse (Turkey), ZHUHAI DL BIOTECH Co., Ltd. (China), CONDALAB (Spain), Genefluidics, Inc. (US), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), Hi-Media Laboratories (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Italy), ELITechGroup (France), Mast Group Ltd. (UK), Biotron Ltd (Australia), InvivoGen (US), MP Biomedicals (US), QuantaMatrix Inc. (South Korea), and PML Microbiologicals Inc. (US), among others are some of the major players operating in the global Antimicrobial Susceptibility Testing Market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984